Publications (876)
-
Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid?
Jentink J, Bakker M, Nijenhuis CM, Wilffert B, de Jong-van den Berg L
Pharmacoepidemiology and Drug Safety, 2010 , 19: 803 - 807
Subjects: Folic Acid, Medication During Pregnancy, Prevention & Risk Factors
Anomalies: Neural Tube Defects -
Down's syndrome: screening and antenatal diagnosis regionally in England and Wales 1989 - 2008
Down's syndrome: screening and antenatal diagnosis regionally in England and Wales 1989 - 2008
de Souza E, Alberman E, Morris J
Journal of Medical Screening, 2010 , 17: (4) 170 - 175
Subjects: Prenatal Screening & Diagnosis
Anomalies: Down Syndrome -
EUROCAT Final Activity Report to European Commission September 2007 to August 2010
EUROCAT Final Activity Report to European Commission September 2007 to August 2010
EUROCAT
EUROCAT Central Registry, University of Ulster, 2010
Subjects: EUROCAT Overview, Surveillance Methodology -
EUROCAT Statistical Monitoring Protocol 2007
EUROCAT Statistical Monitoring Protocol 2007
EUROCAT
EUROCAT Central Registry, University of Ulster, 2010
Subjects: Clusters and Trends, Surveillance Methodology -
EUROCAT Statistical Monitoring Report 2007
EUROCAT Statistical Monitoring Report 2007
EUROCAT
EUROCAT Central Registry, University of Ulster, 2010
Subjects: Clusters and Trends, Prevalence & Perinatal Mortality, Surveillance Methodology -
EUROCAT website data on prenatal detection rates of congenital anomalies
EUROCAT website data on prenatal detection rates of congenital anomalies
Garne E, Dolk H, Loane M, Boyd P and EUROCAT Working Group
Journal of Medical Screening, 2010 , 17: (2) 97 - 98
Subjects: Prenatal Screening & Diagnosis -
First-trimester use of paroxetine and congenital heart defects: a population-based case-control study
First-trimester use of paroxetine and congenital heart defects: a population-based case-control study
Bakker M, Kerstjens-Frederikse WS, Buys CHCM, de Walle H, de Jong-van den Berg L
Birth Defects Research (Part A), 2010 , 88: 94 - 100
Subjects: Medication During Pregnancy, Prevention & Risk Factors
Anomalies: Congenital Heart Anomalies -
Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study
Fluoxetine and infantile hypertrophic pylorus stenosis: a signal from a birth defects-drug exposure surveillance study
Bakker M, de Walle H, Wilffert B, de Jong-van den Berg L
Pharmacoepidemiology and Drug Safety, 2010 , 19: 808 - 813
Subjects: Medication During Pregnancy, Prevention & Risk Factors
Anomalies: Digestive System Anomalies -
Four small supernumerary market chromosomes derived from chromosomes 6, 8, 11 and 12 in a patient with minimal clinical abnormalities: a case report
Four small supernumerary market chromosomes derived from chromosomes 6, 8, 11 and 12 in a patient with minimal clinical abnormalities: a case report
Fernandez-Toral J, Rodriguez L, Plasencia A, Martinez-Frias M-L, Ewers E, Hamid AB, Ziegler M, Liehr T
Journal of Medical Case Reports, 2010 , 4: 239
Subjects: Genetics and Syndromes
Anomalies: Chromosomal (other than Down Syndrome) -
Genotype-phenotype correlations in L1 syndrome: a guide for genetic counselling and mutation analysis
Genotype-phenotype correlations in L1 syndrome: a guide for genetic counselling and mutation analysis
Vos YJ, de Walle H, Bos KK, Stegeman JA, ten Berge AM, Bruining M, van Maarle MC, Elting MW, den Hollander NS, Hamel B, Fortuna AM, Sunde LEM, Stolte-Dijkstra I, Schrander-Stumpel C, Hofstra R
Journal of Medical Genetics, 2010 , 47: 169 - 175
Subjects: Genetics and Syndromes